CONTINUUS awarded SBIR Phase I grant from the NSF
- CONTINUUS Pharma
- Jan 12, 2015
- 1 min read
Updated: Aug 12, 2024
Monday, January 12th, 2015 - General News
CONTINUUS Pharmaceuticals was awarded a Phase I SBIR grant from the National Science Foundation to further develop its breakthrough ICM technology. This Phase I grant consists of $150,000 over a six month period.
Comments